Cargando…

Selection of reliable reference genes for qPCR studies on chondroprotective action

BACKGROUND: Chondroprotective agents (CPA) such as glucosamine, curcumin and diacerein represent potential remedies for the management of osteoarthritis and several studies have been performed on their effects in-vitro and in-vivo. For the investigation of chondroprotective action on chondrocyte gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Toegel, Stefan, Huang, Wenwen, Piana, Claudia, Unger, Frank M, Wirth, Michael, Goldring, Mary B, Gabor, Franz, Viernstein, Helmut
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820791/
https://www.ncbi.nlm.nih.gov/pubmed/17324259
http://dx.doi.org/10.1186/1471-2199-8-13
_version_ 1782132653625966592
author Toegel, Stefan
Huang, Wenwen
Piana, Claudia
Unger, Frank M
Wirth, Michael
Goldring, Mary B
Gabor, Franz
Viernstein, Helmut
author_facet Toegel, Stefan
Huang, Wenwen
Piana, Claudia
Unger, Frank M
Wirth, Michael
Goldring, Mary B
Gabor, Franz
Viernstein, Helmut
author_sort Toegel, Stefan
collection PubMed
description BACKGROUND: Chondroprotective agents (CPA) such as glucosamine, curcumin and diacerein represent potential remedies for the management of osteoarthritis and several studies have been performed on their effects in-vitro and in-vivo. For the investigation of chondroprotective action on chondrocyte gene expression, quantitative real-time RT-PCR is the method of choice. However, validation of applied normalization strategies represents a crucial and sometimes neglected step in the analysis process. Therefore, the present study aimed to determine the expression stability of common reference genes (ACTB, Beta actin; GAPDH, Glyceraldehyde-3-phosphate; B2M, Beta-2-microglobulin; HPRT1, Hypoxanthine phosphoribosyl-transferase I; SDHA, Succinate dehydrogenase complex, subunit A; YWHAZ, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide) under the influence of glucosamine, curcumin and diacerein in the IL-1β-stimulated C-28/I2 chondrocyte model, using the geNorm software tool. RESULTS: CPA treatment of C-28/I2 chondrocytes significantly affected the expression level of many reference genes (p < 0.05). According to their expression stability, geNorm analysis revealed rankings of the 3 most stable genes (from most stable to least stable) as follows: GAPDH, B2M and SDHA in glucosamine treated samples and HPRT1, GAPDH and B2M in curcumin or diacerein treated samples. Interestingly, ACTB was one of the most variably expressed genes throughout all experiments. CONCLUSION: Our study points out the problem of relying on commonly used reference genes without an accurate validation process. For normalization purposes in gene profiling studies on glucosamine action, the genes GAPDH, B2M and SDHA are recommended as single reference genes depending on the expression level of the target gene or more favourably in combination. For experiments with curcumin and diacerein the use of HPRT1, GAPDH and B2M should be considered.
format Text
id pubmed-1820791
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18207912007-03-13 Selection of reliable reference genes for qPCR studies on chondroprotective action Toegel, Stefan Huang, Wenwen Piana, Claudia Unger, Frank M Wirth, Michael Goldring, Mary B Gabor, Franz Viernstein, Helmut BMC Mol Biol Research Article BACKGROUND: Chondroprotective agents (CPA) such as glucosamine, curcumin and diacerein represent potential remedies for the management of osteoarthritis and several studies have been performed on their effects in-vitro and in-vivo. For the investigation of chondroprotective action on chondrocyte gene expression, quantitative real-time RT-PCR is the method of choice. However, validation of applied normalization strategies represents a crucial and sometimes neglected step in the analysis process. Therefore, the present study aimed to determine the expression stability of common reference genes (ACTB, Beta actin; GAPDH, Glyceraldehyde-3-phosphate; B2M, Beta-2-microglobulin; HPRT1, Hypoxanthine phosphoribosyl-transferase I; SDHA, Succinate dehydrogenase complex, subunit A; YWHAZ, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide) under the influence of glucosamine, curcumin and diacerein in the IL-1β-stimulated C-28/I2 chondrocyte model, using the geNorm software tool. RESULTS: CPA treatment of C-28/I2 chondrocytes significantly affected the expression level of many reference genes (p < 0.05). According to their expression stability, geNorm analysis revealed rankings of the 3 most stable genes (from most stable to least stable) as follows: GAPDH, B2M and SDHA in glucosamine treated samples and HPRT1, GAPDH and B2M in curcumin or diacerein treated samples. Interestingly, ACTB was one of the most variably expressed genes throughout all experiments. CONCLUSION: Our study points out the problem of relying on commonly used reference genes without an accurate validation process. For normalization purposes in gene profiling studies on glucosamine action, the genes GAPDH, B2M and SDHA are recommended as single reference genes depending on the expression level of the target gene or more favourably in combination. For experiments with curcumin and diacerein the use of HPRT1, GAPDH and B2M should be considered. BioMed Central 2007-02-26 /pmc/articles/PMC1820791/ /pubmed/17324259 http://dx.doi.org/10.1186/1471-2199-8-13 Text en Copyright © 2007 Toegel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Toegel, Stefan
Huang, Wenwen
Piana, Claudia
Unger, Frank M
Wirth, Michael
Goldring, Mary B
Gabor, Franz
Viernstein, Helmut
Selection of reliable reference genes for qPCR studies on chondroprotective action
title Selection of reliable reference genes for qPCR studies on chondroprotective action
title_full Selection of reliable reference genes for qPCR studies on chondroprotective action
title_fullStr Selection of reliable reference genes for qPCR studies on chondroprotective action
title_full_unstemmed Selection of reliable reference genes for qPCR studies on chondroprotective action
title_short Selection of reliable reference genes for qPCR studies on chondroprotective action
title_sort selection of reliable reference genes for qpcr studies on chondroprotective action
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820791/
https://www.ncbi.nlm.nih.gov/pubmed/17324259
http://dx.doi.org/10.1186/1471-2199-8-13
work_keys_str_mv AT toegelstefan selectionofreliablereferencegenesforqpcrstudiesonchondroprotectiveaction
AT huangwenwen selectionofreliablereferencegenesforqpcrstudiesonchondroprotectiveaction
AT pianaclaudia selectionofreliablereferencegenesforqpcrstudiesonchondroprotectiveaction
AT ungerfrankm selectionofreliablereferencegenesforqpcrstudiesonchondroprotectiveaction
AT wirthmichael selectionofreliablereferencegenesforqpcrstudiesonchondroprotectiveaction
AT goldringmaryb selectionofreliablereferencegenesforqpcrstudiesonchondroprotectiveaction
AT gaborfranz selectionofreliablereferencegenesforqpcrstudiesonchondroprotectiveaction
AT viernsteinhelmut selectionofreliablereferencegenesforqpcrstudiesonchondroprotectiveaction